![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
Background. Elevated circulating levels of pregnancy‐associated plasma protein A (PAPP‐A), a novel marker of atherosclerotic plaque instability, are associated with increased risk of future cardiac events in patients with acute coronary syndromes (ACS). However, little is known of the kinetics or clinical significance of circulating PAPP‐A after plaque rupture in acute ST‐elevation myocardial infarction (STEMI).
Aim. To evaluate the 48‐hour release of pregnancy‐associated plasma protein A (PAPP‐A) and its association with 12‐month outcome in patients with acute ST‐elevation myocardial infarction (STEMI).
Methods. Sixty‐two consecutive STEMI patients were included (40 men and 22 women, median age 67.5 years (range 34–84)), of whom 54 (87.1%) received reperfusion therapy. PAPP‐A was measured at admission and 6–12, 24 and 48 hours thereafter. In 14 patients, samples were obtained also at 1, 2 and 4 hours.
Results. There was an early peak of circulating PAPP‐A during the first 12 hours from symptom onset, followed by rapid normalization. A second, late PAPP‐A elevation was noticed in 20/62 patients (32.3%). Admission PAPP‐A >10.0 mIU/L (highest tertile) was associated (P = 0.049) with increased 12‐month risk of cardiovascular death or non‐fatal myocardial infarction. Moreover, the combination of failed early reperfusion together with late PAPP‐A elevation was strongly (7/13 versus 10/49 patients, P = 0.016) associated with adverse outcome. Admission PAPP‐A did not correlate with admission C‐reactive protein or cardiac troponin I.
Conclusions. PAPP‐A is elevated early in STEMI and then declines rapidly, a pattern consistent with release from the ruptured plaque. The variability of PAPP‐A kinetics at 48 hours reflects the success of reperfusion. This study also shows that PAPP‐A may have prognostic value in STEMI.
| Abbreviations | ||
| PAPP‐A | = | pregnancy‐associated plasma protein A |
| STEMI | = | ST‐elevation myocardial infarction |
| ACS | = | acute coronary syndromes |
| CRP | = | C‐reactive protein |
| cTnI | = | cardiac troponin I |
| PCI | = | percutaneous coronary intervention |
| ECG | = | electrocardiogram |
| proMBP | = | proform of major basic protein |
| TIMI | = | thrombolysis in myocardial infarction |
| MI | = | myocardial infarction |
| Abbreviations | ||
| PAPP‐A | = | pregnancy‐associated plasma protein A |
| STEMI | = | ST‐elevation myocardial infarction |
| ACS | = | acute coronary syndromes |
| CRP | = | C‐reactive protein |
| cTnI | = | cardiac troponin I |
| PCI | = | percutaneous coronary intervention |
| ECG | = | electrocardiogram |
| proMBP | = | proform of major basic protein |
| TIMI | = | thrombolysis in myocardial infarction |
| MI | = | myocardial infarction |
Acknowledgements
This study was supported financially by grants from the EVO funds of the Turku and Helsinki University Hospitals and from Finnish National Technology Agency (Project 40279). Taina Lahti, RN, and Tuula Laukkanen, RN, are acknowledged for expert care of the study subjects and their blood.